Highly active low magnesium hammerhead ribozyme

Journal of Biochemistry

Volumn 145, Issue 4, 2009, Pages 451-459

  Fedoruk Wyszomirska, Agnieszka ^a   Szymański, Maciej ^a   Wyszko, Eliza ^a   Barciszewska, Mirosława Z ^a   Barciszewski, Jan ^a  

^a INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

Author keywords

DNAzyme; Hammerhead ribozyme; HIV; RNA; Tetraloop receptor

Indexed keywords

HAMMERHEAD RIBOZYME; MAGNESIUM; MAGNESIUM ION; MESSENGER RNA; NUCLEIC ACID; RNA; DEOXYRIBOZYME; GLYCOPROTEIN GP 41; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; RIBOZYME;

ARTICLE; CATALYSIS; CELL CULTURE; CONCENTRATION (PARAMETERS); DEGRADATION; GENE EXPRESSION; HYDROLYSIS; IN VITRO SELECTION; NUCLEOTIDE SEQUENCE; RNA CLEAVAGE; BIOCATALYSIS; CHEMISTRY; CONFORMATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME STABILITY; GENE SILENCING; GENETICS; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; KINETICS; METABOLISM; REPORTER GENE; TIME;

BIOCATALYSIS; DNA, CATALYTIC; ENZYME ACTIVATION; ENZYME STABILITY; GENE SILENCING; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HELA CELLS; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; HYDROLYSIS; KINETICS; MAGNESIUM; NUCLEIC ACID CONFORMATION; RECOMBINANT FUSION PROTEINS; RNA, CATALYTIC; RNA, MESSENGER; TIME FACTORS;

EID: 67649646893     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvn182     Document Type: Article

References (51)

1. Kruger, K., Grabowski, P.J., Zaug, A.J., Sands, J., Gottschling, D.E., and Cech, T.R. (1982) Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena. Cell 31, 147-157
2. Guerrier-Takada, C., Gardiner, K., Marsh, T., Pace, N., and Altman, S. (1983) The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35, 849-857
3. Nelson, J.A. and Uhlenbeck, O.C. (2008) Hammerhead redux: does the new structure fit the old biochemical data? RNA 14, 605-615
4. Sarver, N., Cantin, E.M., Chang, P.S., Zaia, J.A., Ladne, P.A., Stephens, D.A., and Rossi, J.J. (1990) Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247, 1222-1225
5. Sun, L.Q., Cairns, M.J., Saravolac, E.G., Baker, A., and Gerlach, W.L. (2000) Catalytic nucleic acids: from lab to applications. Pharmacol. Rev. 52, 325-347
6. Stage-Zimmermann, T.K. and Uhlenbeck, O.C. (1998) Hammerhead ribozyme kinetics. RNA 4, 875-889
7. Bruening, G. (1989) Compilation of self-cleaving sequences from plant virus satellite RNAs and other sources. Methods Enzymol. 180, 546-558
8. Collins, R.F., Gellatly, D.L., Sehgal, O.P., and Abouhaidar, M.G. (1998) Self-cleaving circular RNA associated with rice yellow mottle virus is the smallest viroidlike RNA. Virology 241, 269-275
9. Doudna, J.A. and Cech, T.R. (2002) The chemical repertoire of natural ribozymes. Nature 418, 222-228
10. Citti, L. and Rainaldi, G. (2005) Synthetic hammerhead ribozymes as therapeutic tools to control disease genes. Curr. Gene Ther. 5, 11-24
11. Khan, A.U. and Lal, S.K. (2003) Ribozymes: a modern tool in medicine. J. Biomed. Sci. 10, 457-467
12. Ngok, F.K., Mitsuyasu, R.T., Macpherson, J.L., Boyd, M.P., Symonds, G.P., and Amado, R.G. (2004) Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDS. Methods Mol. Biol. 252, 581-598
13. Khan, A.U. (2006) Ribozyme: a clinical tool. Clin. Chim. Acta 367, 20-27
14. Lustig, B. and Jeang, K.T. (2001) Biological applications of hammerhead ribozymes as anti-viral molecules. Curr. Med. Chem. 8, 1181-1187
15. Schubert, S. and Kurreck, J. (2006) Oligonucleotide-based antiviral strategies. Handb. Exp. Pharmacol. 173, 261-287
16. Hotchkiss, G., Maijgren-Steffensson, C., and Ahrlund- Richter, L. (2004) Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites. Mol. Ther. 10, 172-180
17. Rossi, J.J. (2000) Ribozyme therapy for HIV infection. Adv. Drug Deliv. Rev. 44, 71-78
18. Frankel, A.D. and Young, J.A. (1998) HIV-1: fifteen proteins and an RNA. Annu. Rev. Biochem. 67, 1-25
19. Turner, B.G. and Summers, M.F. (1999) Structural biology of HIV. J. Mol. Biol. 285, 1-32
20. Eckert, D.M. and Kim, P.S. (2001) Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70, 777-810
21. Ebenbichler, C.F., Thielens, N.M., Vornhagen, R., Marschang, P., Arlaud, G.J., and Dierich, M.P. (1991) Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J. Exp. Med. 174, 1417-1424
22. Wang, H., Nishanian, P., and Fahey, J.L. (1995) Characterization of immune suppression by a synthetic HIV gp41 peptide. Cell. Immunol. 161, 236-243
23. Akridge, R.E., Oyafuso, L.K., and Reed, S.G. (1994) IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 153, 5782-5789
24. Ameglio, F., Cordiali Fei, P., Solmone, M., Bonifati, C., Prignano, G., Giglio, A., Caprilli, F., Gentili, G., and Capobianchi, M.R. (1994) Serum IL-10 levels in HIVpositive subjects: correlation with CDC stages. J. Biol. Regul. Homeost. Agents 8, 48-52
25. Rosenberg, Z.F. and Fauci, A.S. (1990) Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol. Today 11, 176-180
26. Klein, S.A., Dobmeyer, J.M., Dobmeyer, T.S., Pape, M., Ottmann, O.G., Helm, E.B., Hoelzer, D., and Rossol, R. (1997) Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 11, 1111-1118
27. Merrill, J.E., Koyanagi, Y., Zack, J., Thomas, L., Martin, F., and Chen, I.S. (1992) Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J. Virol. 66, 2217-2225
28. Koka, P., He, K., Zack, J.A., Kitchen, S., Peacock, W., Fried, I., Tran, T., Yashar, S.S., and Merrill, J.E. (1995) Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J. Exp. Med. 182, 941-951
29. Chen, Y.H., Christiansen, A., and Dierich, M.P. (1995) HIV- 1 gp41 selectively inhibits spontaneous cell proliferation of human cell lines and mitogen- and recall antigen-induced lymphocyte proliferation. Immunol. Lett. 48, 39-44
30. Barcova, M., Kacani, L., Speth, C., and Dierich, M.P. (1998) gp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-gamma production. J. Infect. Dis. 177, 905-913
31. Koutsonikolis, A., Haraguchi, S., Brigino, E.N., Owens, U.E., Good, R.A., and Day, N.K. (1997) HIV-1 recombinant gp41 induces IL-10 expression and production in peripheral blood monocytes but not in T-lymphocytes. Immunol. Lett. 55, 109-113
32. Adamson, D.C., Wildemann, B., Sasaki, M., Glass, J.D., McArthur, J.C., Christov, V.I., Dawson, T.M., and Dawson, V.L. (1996) Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274, 1917-1921
33. Speth, C., Joebstl, B., Barcova, M., and Dierich, M.P. (2000) HIV-1 envelope protein gp41 modulates expression of interleukin-10 and chemokine receptors on monocytes, astrocytes and neurones. AIDS 14, 629-636
34. London, R.E. (1991) Methods for measurement of intracellular magnesium: NMR and fluorescence. Annu. Rev. Physiol. 53, 241-258
35. Romani, A. and Scarpa, A. (1992) Regulation of cell magnesium. Arch. Biochem. Biophys. 298, 1-12
36. 2+-dependent modulation of intracellular Mg2+ concentration with amiloride and KB-R7943 in pig carotid artery. J. Biol. Chem. 278, 47491-47497
37. Burke, D.H. and Greathouse, S.T. (2005) Low-magnesium, trans-cleavage activity by type III, tertiary stabilized hammerhead ribozymes with stem 1 discontinuities. BMC Biochem. 6, 14
38. 2+ requirement: importance of stem-loop II. Chembiochem 3, 1066-1071
39. Nelson, J.A. and Uhlenbeck, O.C. (2008) Minimal and extended hammerheads utilize a similar dynamic reaction mechanism for catalysis. RNA 14, 43-54
40. Fedoruk-Wyszomirska, A., Wyszko, E., Giel-Pietraszuk, M., Barciszewska, M.Z., and Barciszewski, J. (2007) High hydrostatic pressure approach proves RNA catalytic activity without magnesium. Int. J. Biol. Macromol. 41, 30-35
41. Saksmerprome, V., Roychowdhury-Saha, M., Jayasena, S., Khvorova, A., and Burke, D.H. (2004) Artificial tertiary motifs stabilize trans-cleaving hammerhead ribozymes under conditions of submillimolar divalent ions and high temperatures. RNA 10, 1916-1924
42. Costa, M. and Michel, F. (1995) Frequent use of the same tertiary motif by self-folding RNAs. EMBO J. 14, 1276-1285
43. Cate, J.H., Gooding, A.R., Podell, E., Zhou, K., Golden, B.L., Kundrot, C.E., Cech, T.R., and Doudna, J.A. (1996) Crystal structure of a group I ribozyme domain: principles of RNA packing. Science 273, 1678-1685
44. Hodak, J.H., Downey, C.D., Fiore, J.L., Pardi, A., and Nesbitt, D.J. (2005) Docking kinetics and equilibrium of a GAAA tetraloop-receptor motif probed by single-molecule FRET. Proc. Natl Acad. Sci. USA 102, 10505-10510
45. Davis, J.H., Foster, T.R., Tonelli, M., and Butcher, S.E. (2007) Role of metal ions in the tetraloop-receptor complex as analyzed by NMR. RNA 13, 76-86
46. Paolella, G., Sproat, B.S., and Lamond, A.I. (1992) Nuclease resistant ribozymes with high catalytic activity. EMBO J. 11, 1913-1919
47. Braasch, D.A. and Corey, D.R. (2001) Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem. Biol. 8, 1-7
48. Grunweller, A., Wyszko, E., Bieber, B., Jhnel, R., Erdmann, V.A., and Kurreck, J. (2003) Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res. 31, 3185-3193
49. Wahlestedt, C., Salmi, P., Good, L., Kela, J., Johnsson, T., Hökfelt, T., Broberger, C., Porreca, F., Lai, J., Ren, K., Ossipov, M., Koshkin, A., Jakobsen, N., Skouv, J., Oerum, H., Jacobsen, M.H., and Wengel, J. (2000) Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl Acad. Sci. USA 97, 5633-5638
50. Ikawa, Y., Tsuda, K., Matsumura, S., and Inoue, T. (2004) De novo synthesis and development of an RNA enzyme. Proc. Natl Acad. Sci. USA 101, 13750-13755
51. Geary, C., Baudrey, S., and Jaeger, L. (2008) Comprehensive features of natural and in vitro selected GNRA tetraloopbinding receptors. Nucleic Acids Res. 36, 1138-1152